Mathes Company Inc. decreased its holdings in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 2.7% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 91,000 shares of the company’s stock after selling 2,500 shares during the quarter. Mathes Company Inc. owned 0.08% of BlackRock Capital Allocation Term Trust worth $1,493,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently modified their holdings of BCAT. UBS Group AG lifted its holdings in shares of BlackRock Capital Allocation Term Trust by 8.2% in the fourth quarter. UBS Group AG now owns 1,543,167 shares of the company’s stock valued at $23,070,000 after buying an additional 116,638 shares during the period. Prevail Innovative Wealth Advisors LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the second quarter valued at $1,452,000. Stifel Financial Corp lifted its holdings in shares of BlackRock Capital Allocation Term Trust by 30.3% in the fourth quarter. Stifel Financial Corp now owns 488,792 shares of the company’s stock valued at $7,307,000 after buying an additional 113,628 shares during the period. Private Advisor Group LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the fourth quarter valued at $177,000. Finally, Oppenheimer & Co. Inc. lifted its holdings in shares of BlackRock Capital Allocation Term Trust by 18.6% in the first quarter. Oppenheimer & Co. Inc. now owns 29,180 shares of the company’s stock valued at $486,000 after buying an additional 4,586 shares during the period. Institutional investors own 36.12% of the company’s stock.
BlackRock Capital Allocation Term Trust Stock Down 0.1 %
Shares of NYSE BCAT opened at $16.27 on Thursday. BlackRock Capital Allocation Term Trust has a 12 month low of $13.67 and a 12 month high of $17.18. The business has a fifty day simple moving average of $16.35 and a 200-day simple moving average of $16.19.
BlackRock Capital Allocation Term Trust Increases Dividend
About BlackRock Capital Allocation Term Trust
–
Further Reading
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- What Are Growth Stocks and Investing in Them
- 3 Stocks to Neutralize Market Volatility and Build Wealth
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- How Much Can You Make in Stocks in One Month?
- How to Use Stock Screeners to Find Stocks
- This Is the Top Large-Cap Stock Insiders Are Buying
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.